DKS
DICK'S Sporting Goods, Inc.
DKS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over DKS overall, supported by stronger valuation and stronger fundamentals.
DKS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Under pressure | |
| Healthy |
DKS's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
DKS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $84.34 | -42% |
| Forward | 12x | $146 | — |
| Fair | 14x | $124 | -15% |
| Current | 16x | $146 | — |
| Expensive | 18x | $162 | +11% |
Historical ranges are pointers, not guarantees.
DKS's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over DKS in the historical PE scenario, which offers more potential upside but is not a forecast.
DKS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
DKS has the edge over NKE on the outlook, with more favorable valuation and earnings expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
DKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.44 | +37% |
| Q3 2026 | $9.06 | -37% |
| Q2 2026 | $10.27 | -27% |
| Q1 2026 | $9.97 | -29% |
| Q4 2025 | $12.44 | -11% |
| Q3 2025 | $14.33 | +5.1% |
| Q2 2025 | $13.99 | +16% |
| Q1 2025 | $14.05 | +15% |
| Q4 2024 | $13.99 | +25% |
DKS has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
DKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.6B | +53% |
| Q2 2026 | $5.2B | +63% |
| Q1 2026 | $6.2B | +60% |
| Q4 2025 | $4.2B | +36% |
| Q3 2025 | $3.6B | +5% |
| Q2 2025 | $3.2B | +5.2% |
| Q1 2025 | $3.9B | +0.5% |
| Q4 2024 | $3.1B | +0.5% |
DKS has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -4.5 points |
| Q2 2026 | 8.7% | -2.8 points |
| Q1 2026 | 3% | -7 points |
| Q4 2025 | 2.2% | -7.1 points |
| Q3 2025 | 12% | -1.1 points |
| Q2 2025 | 12% | +0.6 points |
| Q1 2025 | 9.9% | +0.3 points |
| Q4 2024 | 9.4% | +0.4 points |
DKS's operating margin was 7.9% last quarter, down 4.5 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over DKS on profitability, with a higher operating margin.
DKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $133M | -55% |
| Q2 2026 | -$84.2M | +$2.5M |
| Q1 2026 | $706.2M | +79% |
| Q4 2025 | -$515.6M | -$376.3M |
| Q3 2025 | $296.2M | +65% |
| Q2 2025 | -$86.7M | -217% |
| Q1 2025 | $394.5M | -33% |
| Q4 2024 | -$139.3M | -$49.6M |
DKS has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
DKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -277K shares |
| 1 year | +11% | +9.1M shares |
| 3 years | +3.9% | +3.3M shares |
| 5 years | -18% | -19.1M shares |
| Available history | +4.1% | +3.5M shares |
DKS has 90M diluted shares, up 11% from a year ago, despite $185M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $141.2M |
| Q1 2026 | $43.5M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $303.7M |
| Q1 2025 | $92.8M |
| Q4 2024 | $6.7M |
DKS spent $185M buying back its own shares over the past year, down 54% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over DKS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
DKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.0x | Very low |
DKS's net debt is less than a year of its operating earnings (EBITDA).
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over DKS on leverage, with a lower net debt burden relative to earnings.
DKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.2 | Neutral |
| Stochastic | 24.3 | Neutral |
DKS's weekly RSI is 38 (neutral) and its Stochastic is 24 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
DKS PE vs Consumer Cyclical Sector
| Metric | DKS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 71 | 47 | 24 pts above |
DKS has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
DKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $141.1 | 3.3% above |
| 20 week MA | $166.3 | 12% below |
| 50 week MA | $194.2 | 25% below |
| 100 week MA | $202.5 | 28% below |
| 200 week MA | $184.0 | 21% below |
DKS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 21% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
DKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $55.6 | +15% |
| 2021 | $55.6 | $103.9 | +87% |
| 2022 | $103.9 | $111.1 | +6.9% |
| 2023 | $111.1 | $147.0 | +32% |
| 2024 | $147.0 | $234.1 | +59% |
| 2025 | $234.1 | $210.3 | -10% |
| 2026 YTD | $210.3 | $145.7 | -31% |
DKS has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.